Search Results
Results found for "Beth Fleck"
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
simulations which revealed different trajectories passing through the gap between TM helices IV and V for both
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
Inside the Lesson: Antagonist Behavior by the Numbers Terry walks through both the pharmacologic and
- Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
In contrast to wild type CXCR4, both R334X and S339fs5 were largely insensitive to CXCL12-promoted degradation
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
chemokine receptor axes play a pivotal role in the recruitment and oriented trafficking of immune cells both
- Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle
mediated via its specific G protein-coupled receptors (GPCRs) named the MT1 receptor, which couples to both
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
the movement of Switch II towards the nucleotide-binding pocket and the stabilization of Switch III, both
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
activation of cytosolic effector proteins: the G proteins after which GPCRs are named, and arrestins which both points of contact it is possible not only to strongly increase binding affinity but also to fine tune both transmembrane domain providing significantly increased binding affinity and providing a means to control both Both properties enable enhanced ligands to avoid being eliminated during the stringent washing process at killing cells than unconjugated MMAE, the Orion CCL5 superagonist analog significantly increased both
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Peroxidase-Induced Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
For Catherine, it became both—after years of uncertainty, pivots, and practical lab experience that grounded
- Fluorescence Polarization in GPCR Research
we have demonstrated that both radioligands and FP assays using CELT-228 A3AR fluorescent antagonist
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Join before year-end to secure both. 👉 Join Terry's Corner Before Dec 31st, 2025 🎧 Dr.
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
The lab has witnessed both spectacular accuracy and puzzling failures.
- The Truth About GPCR Product Launches: Years in the Making
Every GPCR assay that makes it to market carries years of failures, late-night ideas, risky bets, and Built to Win: The IP One Gamble After the success of their cAMP assay, Trinquet’s team took a risky bet More importantly, it worked across formats: from overexpression systems to endogenous GPCRs in native beta
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
Lessons From the Front Lines of Biotech Ajay’s experience in both early-stage biotech and academic science
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
Caenorhabditis elegans was used as an animal model, and both gene expression and functional analysis
- Your GPCR Program Decisions Depend on Good Data Interpretation
Katerina Leftheris : New technologies overcoming peptide limitations with insights from both pharma and
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
The model’s flexibility accommodates both agonism and antagonism as long as the analysis targets equilibrium
- 📰 GPCR Weekly News, January 16 to 22, 2023
Cannabinoid tolerance in S426A/S430A x beta-arrestin 2 knock-out double mutant mice.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Both orphan and well-characterized GPCRs are untapped opportunities for drug development targeting CNS
- Why Opposing Processes Matter for Your Next GPCR Drug
Dobutamine’s dual action on beta and alpha receptors, for example, invites reflex bradycardia that blunts
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
Check out what’s coming in September and October: Sign up for both courses now and score a 25% early
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
localization, trafficking, and dynamics—if your probes preserve function, minimize phototoxicity, and work in both
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
suppresses inhalation while xylazine prolongs exhalation, creating a respiratory cycle that collapses from both
- 📰 GPCR Weekly News, June 24 to 30, 2024
Drugs, and more Molecular glues as potential GPCR therapeutics A high-affinity, cis-on photoswitchable beta from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone Tectonic bets
- 📰 GPCR Weekly News, August 21 to 27, 2023
Molecular Insights into GPCR Function Structural bioinformatics studies of bacterial outer membrane beta-barrel
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
diabetic models have shown that although exendin-P5 induces lower insulin release compared to exendin, both
- 📰 GPCR Weekly News, August 28 to September 3, 2023
stimulates human ovarian cancer cell invasion by upregulating MMP-9 via ERK1/2 signaling CCR7 acts as both
- Therapeutic validation of an orphan G protein‐coupled receptor
GPR84 is a promising target to exploit and the investment in better tools to study its function in both
- VAMP2: a crucial player in the delivery of MOR to the synapse
In addition, VAMP2 can interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Elucidation of a dynamic interplay between a beta-2 adrenergic receptor, its agonist, and stimulatory


















